Listed

Biomea Fusion, Inc.

BMEANasdaqCIK 1840439HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$12.8m, Q2 FY2026
Net income−$8.3m, Q2 FY2026
Biomea Fusion, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m25.3Research and development, Q3 FY2023, three months to 2023-09-30$25.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure30.9Research and development, Q4 FY2023, three months to 2023-12-31$30.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure33.8Research and development, Q1 FY2024, three months to 2024-03-31$33.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure31.8Research and development, Q2 FY2024, three months to 2024-06-30$31.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure27.2Research and development, Q3 FY2024, three months to 2024-09-30$27.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure25.2Research and development, Q4 FY2024, three months to 2024-12-31$25.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure22.9Research and development, Q1 FY2025, three months to 2025-03-31$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure16.6Research and development, Q2 FY2025, three months to 2025-06-30$16.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure14.4Research and development, Q3 FY2025, three months to 2025-09-30$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure8.1Research and development, Q4 FY2025, three months to 2025-12-31$8.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure9.1Research and development, Q1 FY2026, three months to 2026-03-31$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure9.1Research and development, Q2 FY2026, three months to 2026-06-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Operating income$m(31.1)Operating income, Q3 FY2023, three months to 2023-09-30−$31.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(37.3)Operating income, Q4 FY2023, three months to 2023-12-31−$37.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(41.1)Operating income, Q1 FY2024, three months to 2024-03-31−$41.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure(38.9)Operating income, Q2 FY2024, three months to 2024-06-30−$38.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure(34.0)Operating income, Q3 FY2024, three months to 2024-09-30−$34.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(30.1)Operating income, Q4 FY2024, three months to 2024-12-31−$30.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(29.7)Operating income, Q1 FY2025, three months to 2025-03-31−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(21.3)Operating income, Q2 FY2025, three months to 2025-06-30−$21.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(20.8)Operating income, Q3 FY2025, three months to 2025-09-30−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(11.7)Operating income, Q4 FY2025, three months to 2025-12-31−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure(12.8)Operating income, Q1 FY2026, three months to 2026-03-31−$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(12.8)Operating income, Q2 FY2026, three months to 2026-06-30−$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Net income$m(28.4)Net income, Q3 FY2023, three months to 2023-09-30−$28.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(34.9)Net income, Q4 FY2023, three months to 2023-12-31−$34.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(39.1)Net income, Q1 FY2024, three months to 2024-03-31−$39.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(37.3)Net income, Q2 FY2024, three months to 2024-06-30−$37.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(32.8)Net income, Q3 FY2024, three months to 2024-09-30−$32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(29.3)Net income, Q4 FY2024, three months to 2024-12-31−$29.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(29.3)Net income, Q1 FY2025, three months to 2025-03-31−$29.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(20.7)Net income, Q2 FY2025, three months to 2025-06-30−$20.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(16.4)Net income, Q3 FY2025, three months to 2025-09-30−$16.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure4.6Net income, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure(12.4)Net income, Q1 FY2026, three months to 2026-03-31−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(8.3)Net income, Q2 FY2026, three months to 2026-06-30−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Diluted EPS$ per share(0.80)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(0.98)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(1.09)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure(1.03)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure(0.91)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(0.81)Diluted EPS, Q4 FY2024, three months to 2024-12-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(0.80)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(0.51)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(0.27)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(0.12)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Basic EPS$ per share(0.80)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(0.98)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(1.09)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure(1.03)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure(0.91)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure(0.81)Basic EPS, Q4 FY2024, three months to 2024-12-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(0.80)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(0.51)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure(0.27)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figurenot reported(0.17)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(0.12)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure

Balance sheet

Cash and equivalents$34.8m, Q2 FY2026
Shareholders' equity$12.1m, Q2 FY2026
Biomea Fusion, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m199Cash and equivalents, Q3 FY2023, at 2023-09-30$199.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure177Cash and equivalents, FY2023, at 2023-12-31$176.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure145Cash and equivalents, Q1 FY2024, at 2024-03-31$144.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure113Cash and equivalents, Q2 FY2024, at 2024-06-30$113.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure88.0Cash and equivalents, Q3 FY2024, at 2024-09-30$88.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure58.3Cash and equivalents, FY2024, at 2024-12-31$58.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure35.9Cash and equivalents, Q1 FY2025, at 2025-03-31$35.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure56.2Cash and equivalents, Q2 FY2025, at 2025-06-30$56.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure46.6Cash and equivalents, Q3 FY2025, at 2025-09-30$46.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure55.8Cash and equivalents, FY2025, at 2025-12-31$55.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure44.7Cash and equivalents, Q1 FY2026, at 2026-03-31$44.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure34.8Cash and equivalents, Q2 FY2026, at 2026-06-30$34.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Current assets$m203Current assets, Q3 FY2023, at 2023-09-30$202.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-30, accession 0000950170-23-056381.Report this figure179Current assets, FY2023, at 2023-12-31$179.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure148Current assets, Q1 FY2024, at 2024-03-31$147.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052082.Report this figure116Current assets, Q2 FY2024, at 2024-06-30$116.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0000950170-24-088584.Report this figure93.6Current assets, Q3 FY2024, at 2024-09-30$93.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure68.3Current assets, FY2024, at 2024-12-31$68.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure44.7Current assets, Q1 FY2025, at 2025-03-31$44.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure64.7Current assets, Q2 FY2025, at 2025-06-30$64.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure49.4Current assets, Q3 FY2025, at 2025-09-30$49.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure58.1Current assets, FY2025, at 2025-12-31$58.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure46.3Current assets, Q1 FY2026, at 2026-03-31$46.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure36.4Current assets, Q2 FY2026, at 2026-06-30$36.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Total assets$m225Total assets, Q3 FY2023, at 2023-09-30$225.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-30, accession 0000950170-23-056381.Report this figure200Total assets, FY2023, at 2023-12-31$199.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure168Total assets, Q1 FY2024, at 2024-03-31$168.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0000950170-24-052082.Report this figure136Total assets, Q2 FY2024, at 2024-06-30$136.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0000950170-24-088584.Report this figure110Total assets, Q3 FY2024, at 2024-09-30$110.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure79.9Total assets, FY2024, at 2024-12-31$79.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure55.1Total assets, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure73.2Total assets, Q2 FY2025, at 2025-06-30$73.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure55.2Total assets, Q3 FY2025, at 2025-09-30$55.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure58.6Total assets, FY2025, at 2025-12-31$58.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure46.4Total assets, Q1 FY2026, at 2026-03-31$46.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure36.9Total assets, Q2 FY2026, at 2026-06-30$36.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Current liabilities$m16.2Current liabilities, Q3 FY2023, at 2023-09-30$16.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-30, accession 0000950170-23-056381.Report this figure22.9Current liabilities, FY2023, at 2023-12-31$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure25.3Current liabilities, Q1 FY2024, at 2024-03-31$25.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052082.Report this figure25.2Current liabilities, Q2 FY2024, at 2024-06-30$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0000950170-24-088584.Report this figure27.6Current liabilities, Q3 FY2024, at 2024-09-30$27.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure21.7Current liabilities, FY2024, at 2024-12-31$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure19.8Current liabilities, Q1 FY2025, at 2025-03-31$19.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure17.6Current liabilities, Q2 FY2025, at 2025-06-30$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure15.6Current liabilities, Q3 FY2025, at 2025-09-30$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure11.1Current liabilities, FY2025, at 2025-12-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure9.3Current liabilities, Q1 FY2026, at 2026-03-31$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure10.5Current liabilities, Q2 FY2026, at 2026-06-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Total liabilities$m25.5Total liabilities, Q3 FY2023, at 2023-09-30$25.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-30, accession 0000950170-23-056381.Report this figure30.7Total liabilities, FY2023, at 2023-12-31$30.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure33.2Total liabilities, Q1 FY2024, at 2024-03-31$33.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0000950170-24-052082.Report this figure32.2Total liabilities, Q2 FY2024, at 2024-06-30$32.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-31, accession 0000950170-24-088584.Report this figure34.4Total liabilities, Q3 FY2024, at 2024-09-30$34.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure28.4Total liabilities, FY2024, at 2024-12-31$28.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure26.3Total liabilities, Q1 FY2025, at 2025-03-31$26.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure45.7Total liabilities, Q2 FY2025, at 2025-06-30$45.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure39.6Total liabilities, Q3 FY2025, at 2025-09-30$39.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure29.0Total liabilities, FY2025, at 2025-12-31$29.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure27.7Total liabilities, Q1 FY2026, at 2026-03-31$27.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure24.7Total liabilities, Q2 FY2026, at 2026-06-30$24.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Shareholders' equity$m200Shareholders' equity, Q3 FY2023, at 2023-09-30$199.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-29, accession 0000950170-24-118366.Report this figure169Shareholders' equity, FY2023, at 2023-12-31$169.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure135Shareholders' equity, Q1 FY2024, at 2024-03-31$135.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure104Shareholders' equity, Q2 FY2024, at 2024-06-30$103.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure76.0Shareholders' equity, Q3 FY2024, at 2024-09-30$76.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure51.6Shareholders' equity, FY2024, at 2024-12-31$51.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure28.7Shareholders' equity, Q1 FY2025, at 2025-03-31$28.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure27.5Shareholders' equity, Q2 FY2025, at 2025-06-30$27.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure15.6Shareholders' equity, Q3 FY2025, at 2025-09-30$15.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure29.6Shareholders' equity, FY2025, at 2025-12-31$29.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure18.7Shareholders' equity, Q1 FY2026, at 2026-03-31$18.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure12.1Shareholders' equity, Q2 FY2026, at 2026-06-30$12.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure

Cash flow

Operating cash flow−$10.0m, Q2 FY2026
Capital expenditure$0, Q3 FY2025
Biomea Fusion, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(23.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$23.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-29, accession 0000950170-24-118366. Derived: 9-month figure less the 6-month figure.Report this figure(22.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$22.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure(32.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$32.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure(32.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$32.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000950170-25-103041. Derived: 6-month figure less the 3-month figure.Report this figure(25.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264679. Derived: 9-month figure less the 6-month figure.Report this figure(30.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure(25.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(19.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$19.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335085. Derived: 6-month figure less the 3-month figure.Report this figure(11.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264679. Derived: 9-month figure less the 6-month figure.Report this figure(13.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure(11.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure(10.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335085. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-29, accession 0000950170-24-118366. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$59.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000950170-25-103041. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$186.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264679. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001193125-26-121825. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000950170-25-103041. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264679. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reported

Shares

Diluted shares (weighted)72.36m, Q2 FY2026
Biomea Fusion, Inc., shares, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares35.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3035,348,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure35.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3035,653,988 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure35.8Diluted shares (weighted), Q4 FY2023, three months to 2023-12-3135,754,165 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure35.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3135,890,370 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0000950170-25-063543.Report this figure36.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3036,043,561 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000950170-25-103041.Report this figure36.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3036,220,736 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure36.3Diluted shares (weighted), Q4 FY2024, three months to 2024-12-3136,265,001 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure36.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3136,627,148 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure40.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3040,630,403 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure59.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3059,848,325 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264679.Report this figure72.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3172,299,440 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-217074.Report this figure72.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3072,360,235 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure

Shares outstanding: 72.48mShares outstanding, period not labelled, at 2026-07-3172,483,852 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.